Notably, RAS mutations are prevalent in 15-30% of all human cancers, while BRAF mutations are found in 30-60% of melanomas, 30-50% of thyroid cancers, and 5-20% of colorectal cancers. This evidence concerns the gene BRAF and melanoma.